Abstract
Any plan or surveillance, especially expensive surveillance, must take into account the incidence of mahgnant degeneration of Barrett’s epithehum and the probabihty that early identification of such change can favorably affect the outcome.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Spechler SJ, Stuart JS, Raj KG (1986) Barrett’s esophagus N Engl J Med 315: 362–371
Cameron AJ, Ott BJ, Payne WS (1985) The Incidence of adenocarcinoma in columnar-lined (Barrett’s) Esophagus. N J Med 313: 857–859
Spechler SJ, et al (1984) Adenocarcinoma and Barrett’s Esophagus: an overrated risk? Gastroenterology 87: 924–933
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hiebert, C.A., Reboud, E. (1989). What should be the approach to surveillance of these patients?. In: Giuli, R., McCallum, R.W. (eds) Benign Lesions of the Esophagus and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73055-9_204
Download citation
DOI: https://doi.org/10.1007/978-3-642-73055-9_204
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73057-3
Online ISBN: 978-3-642-73055-9
eBook Packages: Springer Book Archive